Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Analyst Opinions

IMAC Holdings (BACK) Stock Rose nearly 19% Pre-Hours. How Did That Happen?

October 26, 2022
in Analyst Opinions

IMAC Holdings Inc. (NASD: BACK) is soaring on the charts today, rising 18.67% to trade at $0.41 at the last check in premarket trading, carrying over the previous session’s uptrend to increase by over 5%.

What is driving the price of BACK stock higher?

IMAC Holdings (BACK) disclosed last Friday that it has joined together with Evoke Chiropractic Coaching to inform and market its new line of organic, whole-food supplements to its network of medical practices. The relationship officially kicks off on October 21 during an athlete panel presentation at the Evoke 3rd Annual Conference in St. Louis, Missouri.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

The panel is made up of collegiate All-American and 2015 Super Bowl victor Sylvester Williams, Hall of Fame shortstop and 1982 World Series champion Ozzie Smith, Hall of Fame thoroughbred jockey Rosemary Homeister, NBA veteran and former VP of the NBA Players Association Maurice Evans, and Hall of Fame thoroughbred jockey Rosemary Homeister.

The panel discussion on nutrition, supplements, and health was moderated by Dr. Ben Lerner, Chief Operating Officer of IMAC Holdings, in front of a group of medical professionals, students, and business people. Participants had the chance to offer the IMAC supplement line in their workplaces, with a percentage of each sale going to support the goals of Evoke.

Evoke Chiropractic seeks to help minority chiropractors establish a profitable company and a long-lasting practice. The Evoke Conference was founded by founding partners Dr. Edgar Everett III, Dr. Xavier Tipler, and Dr. Frank Vaught Jr. to raise awareness of the chiropractic profession and the value of diversity and inclusion in business.

An exceptional and potent chance to support the Evoke cause is to present alongside this top group of athletes, community leaders, and business leaders. BACK’s decision to offer this degree of assistance to physicians through its novel seed-to-bottle formulations was a significant development that led to the development of yet another cutting-edge strategy for BACK to improve community health across the nation.

A similar move:

In the hormone optimization market, Biote Corp., a fast growth, unique medical practice-building company, and BACK have partnered. Through that alliance, IMAC Holdings (BACK), which operates a network of outpatient clinics that provide orthopedic, regenerative, and advanced, non-surgical medical procedures, will expand the range of Biote services it offers.

Tags: BACK StockBACK Stock PriceIMAC HoldingsIMAC Holdings IncIMAC Holdings Inc StockIMAC Holdings StockNASD:BACKNASDAQ: BACK

Related Posts

What Led The Verona Pharma (VRNA) Stock To Increase 34% Pre-Market?

December 20, 2022

Top Ratings Upgrades for December 1: Avadel Pharmaceuticals (AVDL), Cooper Companies (COO), SoundHound AI (SOUN)

December 1, 2022

5 Hot Pre-Market Movers Stock to Watch

November 11, 2022

What Happened On Thursday To Make Guardion Health (GHSI) Stock Surge?

October 6, 2022

Why Is 9 Meters Biopharma (NMTR) Stock Increasing Pre-Market Today?

September 27, 2022

Ocugen Inc. (OCGN): What Top Wall Street Players are Saying

August 29, 2022
Next Post

A breakdown of the latest mutual funds holding Evolv Technologies Holdings Inc. (EVLV)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Investor Insight: TScan Therapeutics Inc. (TCRX) Goes Ballistic – Investor Confidence on the Rise

2 days ago

There is little time left for MaxLinear Inc. (MXL) to reach its 1-year target estimate. How soon will it surpass it?

4 months ago

The shares of InMode Ltd. (INMD) have recorded the market capitalization of 2.92B

3 weeks ago

Does Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) have deteriorating prospects?

2 months ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?
  • There is little time left for S&T Bancorp Inc. (STBA) to reach its 1-year target estimate. How soon will it surpass it?

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch